Why is SMS Pharmaceuticals Ltd falling/rising?

Strong Price Performance Against Benchmarks

SMS Pharmaceuticals has demonstrated remarkable resilience and growth compared to the broader market indices. Over the past week, the stock surged by 8.66%, significantly outperforming the Sensex’s modest 0.88% gain. This trend extends over longer periods, with the stock delivering a 6.02% increase in the last month while the Sensex declined by 0.32%. Year-to-date, SMS Pharma has appreciated by 8.25%, dwarfing the Sensex’s 0.26% rise. The company’s one-year return of 30.79% far exceeds the benchmark’s 7.85%, while its three-year and five-year returns stand at an impressive 312.72% and 164.58%, respectively, compared to the Sensex’s 41.57% and 76.39%. These figures underscore the stock’s consistent outperformance and growing investor appeal.

New 52-Week High and Technical Strength

On the day in question, SMS Pharmaceuticals hit a new 52-week high of ₹341.05, marking a 3.35% intraday increase. The stock has been on a three-day winning streak, accumulating a 9.11% return during this period. It is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong technical momentum. This upward trajectory is further supported by rising investor participation, with delivery volumes on 02 Jan reaching 2.68 lakh shares—a staggering 311.67% increase over the five-day average. Such heightened liquidity and trading activity indicate robust market interest and confidence in the stock’s prospects.

Fundamental Strengths Driving Investor Confidence

The company’s recent financial disclosures have reinforced its positive outlook. SMS Pharmaceuticals reported net sales of ₹438.48 crore for the latest six-month period, reflecting a robust growth rate of 21.40%. This strong top-line expansion is complemented by an impressive return on capital employed (ROCE) of 12.36% for the half-year, indicating efficient utilisation of capital resources. Additionally, the company maintains a conservative debt-equity ratio of 0.45 times, the lowest in its recent history, which suggests a prudent capital structure and reduced financial risk. These fundamentals provide a solid foundation for sustained growth and profitability, attracting long-term investors.

Consistent Outperformance Over Time

SMS Pharmaceuticals has consistently outperformed the broader market and its sector peers over multiple time horizons. Notably, the stock has delivered annual returns exceeding those of the BSE500 index in each of the last three years. This track record of superior performance highlights the company’s ability to generate shareholder value through operational excellence and strategic growth initiatives. The sustained upward trend in share price reflects market recognition of these strengths and growing optimism about the company’s future prospects.

Conclusion: Why SMS Pharmaceuticals Is Rising

The rise in SMS Pharmaceuticals Ltd’s share price on 05-Jan is underpinned by a combination of strong financial results, technical strength, and sustained investor interest. The company’s impressive sales growth, efficient capital utilisation, and low leverage have bolstered market confidence. Coupled with consistent outperformance relative to benchmarks and sector peers, these factors have driven the stock to new highs and attracted increased trading volumes. While the broader market has shown modest gains, SMS Pharmaceuticals has distinguished itself as a compelling investment proposition, reflected in its robust price appreciation and positive momentum.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →